For several years now, we have seen from randomized controlled trials that SGLT2 inhibitors and GLP-1 receptor agonists have the ability to reduce the risk of cardiovascular disease, which includes stroke, heart attack and death, said Cheryl Bushnell, MD, a professor in the department of neurology at Wake Forest University
The drugs can cost about $1,000 a month and are usually covered for other conditions like diabetes
GLP-1 ( glucagon-like peptide-1 ) is a hormone that regulates blood sugar, appetite, and insulin secretion
The Mechanism Behind Gynecomastia When one experiences weight gain it leads to an increase in chest fat, which accumulates in an area naturally containing breast tissue
Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction